[MEDICAL CANNABIS]

Harefuah. 2016 Feb;155(2):79-82, 133.
[Article in Hebrew]

Abstract

The cannabis plant has been known to humanity for centuries as a remedy for pain, diarrhea and inflammation. Current research is inspecting the use of cannabis for many diseases, including multiple sclerosis, epilepsy, dystonia, and chronic pain. In inflammatory conditions cannabinoids improve pain in rheumatoid arthritis and:pain and diarrhea in Crohn's disease. Despite their therapeutic potential, cannabinoids are not free of side effects including psychosis, anxiety, paranoia, dependence and abuse. Controlled clinical studies investigating the therapeutic potential of cannabis are few and small, whereas pressure for expanding cannabis use is increasing. Currently, as long as cannabis is classified as an illicit drug and until further controlled studies are performed, the use of medical cannabis should be limited to patients who failed conventional better established treatment.

Publication types

  • English Abstract

MeSH terms

  • Cannabis
  • Chronic Pain / drug therapy*
  • Chronic Pain / etiology
  • Crohn Disease / complications
  • Diarrhea / drug therapy*
  • Diarrhea / etiology
  • Drug and Narcotic Control* / methods
  • Drug and Narcotic Control* / organization & administration
  • Epilepsy / drug therapy*
  • Humans
  • Inappropriate Prescribing / legislation & jurisprudence
  • Inflammation / drug therapy
  • Inflammation / etiology
  • Israel
  • Medical Marijuana* / adverse effects
  • Medical Marijuana* / therapeutic use
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy*
  • Phytotherapy / methods
  • Phytotherapy / psychology
  • Phytotherapy / standards
  • Psychoses, Substance-Induced / etiology
  • Psychoses, Substance-Induced / prevention & control*
  • Substance-Related Disorders / etiology
  • Substance-Related Disorders / prevention & control*

Substances

  • Medical Marijuana